4//SEC Filing
Moore Matthew Richard 4
Accession 0001787306-24-000036
CIK 0001787306other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:08 PM ET
Size
5.6 KB
Accession
0001787306-24-000036
Insider Transaction Report
Form 4
Moore Matthew Richard
SVP and Chief Business Officer
Transactions
- Sale
Common Stock
2024-03-04$11.12/sh−3,468$38,568→ 146,020 total
Footnotes (2)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units.
- [F2]The transaction was executed in multiple trades in prices ranging from $11.000 to $11.3200, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001840191
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:08 PM ET
- Size
- 5.6 KB